Clinical study of squamous cell carcinoma of the thyroid gland

Takeichiro Aso, Hideyuki Kiyohara, Mioko Matsuo, Fumihide Rikimaru, Junichi Fukushima, Yuichiro Higaki, Muneyuki Masuda

Research output: Contribution to journalArticle

Abstract

Squamous cell carcinoma of the thyroid gland is a rare disease. Although several mechanisms have been proposed, the pathogenesis of the disease is not known. A majority of cases are at an advanced stage at the time of diagnosis and the clinical course is extremely aggressive. This is because the tumor often invades directly into neighboring organs, metastasizes, and is refractory to conventional treatments. As a result, a clinically effective therapy is not established for this biologically aggressive tumor with extremely poor prognosis. From January 2000 to December 2012, there were three cases of squamous cell carcinoma of the thyroid gland, accounting for 1.1% of all thyroid cancers treated in our department. Two patients who were treated with radical surgery plus chemoradiotherapy developed distant metastases. One of them died at 20 months after the initial treatment, while the other remained alive with metastatic tumor for 44 months. One inoperable patient died 5 months after CRT. For operable cases, multimodality treatment with radical surgery may be preferable, leading to longer survival.

Original languageEnglish
Pages (from-to)68-75
Number of pages8
JournalJapanese Journal of Head and Neck Cancer
Volume43
Issue number1
DOIs
Publication statusPublished - Jan 1 2017
Externally publishedYes

Fingerprint

Squamous Cell Carcinoma
Thyroid Gland
Neoplasms
Chemoradiotherapy
Therapeutics
Rare Diseases
Thyroid Neoplasms
Neoplasm Metastasis
Survival
Clinical Studies

All Science Journal Classification (ASJC) codes

  • Otorhinolaryngology
  • Oncology

Cite this

Aso, T., Kiyohara, H., Matsuo, M., Rikimaru, F., Fukushima, J., Higaki, Y., & Masuda, M. (2017). Clinical study of squamous cell carcinoma of the thyroid gland. Japanese Journal of Head and Neck Cancer, 43(1), 68-75. https://doi.org/10.5981/jjhnc.43.68

Clinical study of squamous cell carcinoma of the thyroid gland. / Aso, Takeichiro; Kiyohara, Hideyuki; Matsuo, Mioko; Rikimaru, Fumihide; Fukushima, Junichi; Higaki, Yuichiro; Masuda, Muneyuki.

In: Japanese Journal of Head and Neck Cancer, Vol. 43, No. 1, 01.01.2017, p. 68-75.

Research output: Contribution to journalArticle

Aso, T, Kiyohara, H, Matsuo, M, Rikimaru, F, Fukushima, J, Higaki, Y & Masuda, M 2017, 'Clinical study of squamous cell carcinoma of the thyroid gland', Japanese Journal of Head and Neck Cancer, vol. 43, no. 1, pp. 68-75. https://doi.org/10.5981/jjhnc.43.68
Aso, Takeichiro ; Kiyohara, Hideyuki ; Matsuo, Mioko ; Rikimaru, Fumihide ; Fukushima, Junichi ; Higaki, Yuichiro ; Masuda, Muneyuki. / Clinical study of squamous cell carcinoma of the thyroid gland. In: Japanese Journal of Head and Neck Cancer. 2017 ; Vol. 43, No. 1. pp. 68-75.
@article{0fe46ee9374d48749cf67572ae22fde0,
title = "Clinical study of squamous cell carcinoma of the thyroid gland",
abstract = "Squamous cell carcinoma of the thyroid gland is a rare disease. Although several mechanisms have been proposed, the pathogenesis of the disease is not known. A majority of cases are at an advanced stage at the time of diagnosis and the clinical course is extremely aggressive. This is because the tumor often invades directly into neighboring organs, metastasizes, and is refractory to conventional treatments. As a result, a clinically effective therapy is not established for this biologically aggressive tumor with extremely poor prognosis. From January 2000 to December 2012, there were three cases of squamous cell carcinoma of the thyroid gland, accounting for 1.1% of all thyroid cancers treated in our department. Two patients who were treated with radical surgery plus chemoradiotherapy developed distant metastases. One of them died at 20 months after the initial treatment, while the other remained alive with metastatic tumor for 44 months. One inoperable patient died 5 months after CRT. For operable cases, multimodality treatment with radical surgery may be preferable, leading to longer survival.",
author = "Takeichiro Aso and Hideyuki Kiyohara and Mioko Matsuo and Fumihide Rikimaru and Junichi Fukushima and Yuichiro Higaki and Muneyuki Masuda",
year = "2017",
month = "1",
day = "1",
doi = "10.5981/jjhnc.43.68",
language = "English",
volume = "43",
pages = "68--75",
journal = "Japanese Journal of Head and Neck Cancer",
issn = "1349-5747",
publisher = "Nihon Tokeibu Gan Gakkai",
number = "1",

}

TY - JOUR

T1 - Clinical study of squamous cell carcinoma of the thyroid gland

AU - Aso, Takeichiro

AU - Kiyohara, Hideyuki

AU - Matsuo, Mioko

AU - Rikimaru, Fumihide

AU - Fukushima, Junichi

AU - Higaki, Yuichiro

AU - Masuda, Muneyuki

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Squamous cell carcinoma of the thyroid gland is a rare disease. Although several mechanisms have been proposed, the pathogenesis of the disease is not known. A majority of cases are at an advanced stage at the time of diagnosis and the clinical course is extremely aggressive. This is because the tumor often invades directly into neighboring organs, metastasizes, and is refractory to conventional treatments. As a result, a clinically effective therapy is not established for this biologically aggressive tumor with extremely poor prognosis. From January 2000 to December 2012, there were three cases of squamous cell carcinoma of the thyroid gland, accounting for 1.1% of all thyroid cancers treated in our department. Two patients who were treated with radical surgery plus chemoradiotherapy developed distant metastases. One of them died at 20 months after the initial treatment, while the other remained alive with metastatic tumor for 44 months. One inoperable patient died 5 months after CRT. For operable cases, multimodality treatment with radical surgery may be preferable, leading to longer survival.

AB - Squamous cell carcinoma of the thyroid gland is a rare disease. Although several mechanisms have been proposed, the pathogenesis of the disease is not known. A majority of cases are at an advanced stage at the time of diagnosis and the clinical course is extremely aggressive. This is because the tumor often invades directly into neighboring organs, metastasizes, and is refractory to conventional treatments. As a result, a clinically effective therapy is not established for this biologically aggressive tumor with extremely poor prognosis. From January 2000 to December 2012, there were three cases of squamous cell carcinoma of the thyroid gland, accounting for 1.1% of all thyroid cancers treated in our department. Two patients who were treated with radical surgery plus chemoradiotherapy developed distant metastases. One of them died at 20 months after the initial treatment, while the other remained alive with metastatic tumor for 44 months. One inoperable patient died 5 months after CRT. For operable cases, multimodality treatment with radical surgery may be preferable, leading to longer survival.

UR - http://www.scopus.com/inward/record.url?scp=85020917591&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85020917591&partnerID=8YFLogxK

U2 - 10.5981/jjhnc.43.68

DO - 10.5981/jjhnc.43.68

M3 - Article

AN - SCOPUS:85020917591

VL - 43

SP - 68

EP - 75

JO - Japanese Journal of Head and Neck Cancer

JF - Japanese Journal of Head and Neck Cancer

SN - 1349-5747

IS - 1

ER -